Equilis Te (pack of 10)

   Product Ref: INEQU13 Category: E

Temporarily Out of Stock



Target species Horses Indications for use Active immunisation of horses from 6 months of age against tetanus to prevent mortality. Onset of immunity: 2 weeks after the primary vaccination course. Duration of immunity: 17 months after the primary vaccination course, 24 months after the first revaccination. Contra-indications None. Special warnings for each target species Foals should not be vaccinated before the age of 6 months, especially when born to mares that were revaccinated in the last two months of gestation, because of possible interference by maternally derived antibodies Special precautions for use Only healthy animals should be vaccinated. Operator warning: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions A diffuse hard or soft swelling (max. diameter 5 cm) may rarely occur at the injection site, regressing within 2 days. In very rare cases a local reaction exceeding 5 cm and possibly persisting longer than 2 days may occur. Pain at the injection site can occur in rare cases which may result in temporary functional discomfort (stiffness). In very rare cases, fever, sometimes accompanied by lethargy and inappetence, may occur for 1 day, and up to 3 days in exceptional circumstances. The frequency of adverse reactions is defined using the following convention: -very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) -common (more than 1 but less than 10 animals in 100 animals) -uncommon (more than 1 but less than 10 animals in 1,000 animals) -rare (more than 1 but less than 10 animals in 10,000 animals) -very rare (less than 1 animal in 10,000 animals, including isolated reports). Use during pregnancy, lactation or lay Can be used during pregnancy and lactation. Interactions Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Tetanus Antitoxin Behring. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Vat Rate: 20%

Royal Mail 2nd Class / Parcel Force 48

UK to UK :Normally arrives in 2-4 business days.

UK to Ireland :Normally arrives in 4-6 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage

 

----------------------------------------------------------------------------------------------------------------

 

Royal Mail First Class / Parcel Force 24

UK to UK :Normally arrives in 1-2 business days.

UK to Ireland 3-4 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note :Trackable , Royal Mail insured up to £50.

 

--------------------------------------------------------------------------------------------------------

Parcel Force Express AM Guaranteed before Midday.

UK to UK only . UP to 5KG Max Weight

Arrives next day before 12 noon, requires a signature.

 

Parcel Forcel Terms & Conditions apply

 

Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.

 

You must be logged in to write review
Category POM-V
Temperature Refrigerated
MA/VM/EU No: EU/2/05/055/001-002
Species
  • horse
VMD Link Product Information Database (defra.gov.uk)
NOAH Link https://www.noahcompendium.co.uk/?id=-454711
Dosage Amounts to be administered and administration route Intramuscular use. Allow the vaccine to reach room temperature before use. Vaccination schedule: Primary vaccination course Administer one dose (1ml), by intramuscular injection, according to the following schedule: Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later. Revaccination:The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended (see schedule). Description: h-992 In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later) Concurrent active and passive immunisation (emergency vaccination) The vaccine can be used together with Tetanus Antitoxin Behring for treatment of injured horses that have not been immunised against tetanus. In that case, the first dose (V1) of vaccine can be given concurrently with the appropriate prophylactic dose of Tetanus Antitoxin Behring at a separate injection site, using separate syringes and needles. This will lead to a passive protection against tetanus for at least 21 days after concurrent administration. The second dose of the vaccine (V2) should be administered 4 weeks later. A third vaccination with Equilis Te should be repeated at least four weeks later. Concurrent use of Equilis Te and Tetanus Antitoxin Behring may reduce active immunity against tetanus compared to horses vaccinated with Equilis Te in the absence of tetanus antitoxin serum. Overdose Following the administration of a double dose of vaccine, no side effects other than those described under section "Adverse reactions" have been observed except for some depression at the day of vaccination.
Withdrawals Withdrawal periods Zero days.